Anti-CD 19 CAR-T Cell Therapy in Patients With ANCA Vasculitis

Clinical trial NCT06590545 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06590545
Sponsor: David Simon
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

ANCA-IgG-positive ANCA Associated Vasculitis

Start date: 2025-01-01
Primary completion: 2027-01-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.